Articles | Open Access | DOI: https://doi.org/10.37547/ijmscr/Volume03Issue04-09

USE OF BETASERCA IN PATIENTS WITH HD WITH COCHLEOVESTIBULAR DISORDERS

U.S. Khasanov , Researcher Tashkent Medical Academy, Uzbekistan
N.A. Akhunjhanov , Researcher Tashkent Medical Academy, Uzbekistan
G.S. Khaydarova , Researcher Tashkent Medical Academy, Uzbekistan
K.E. Shaykhova , Researcher Tashkent Medical Academy, Uzbekistan
U.P. Abdullaev , Researcher Tashkent Medical Academy, Uzbekistan

Abstract

Betahistine dihydrochloride is a synthetic drug that has the ability to bind to H1 histamine receptors, which are embedded in the neuroreceptor cells of the inner ear. It has a powerful stimulating effect by increasing the release of neurotransmitters (histamine) from the nerve endings of the inner ear receptor cells into the synapse. The neurotransmitter acts on the precapillary sphincters, causing vasodilation of the vessels of the inner ear, increasing their permeability and thereby normalizing intralabyrinthine pressure, i.e. eliminating hydrops.

Keywords

Betahistine dihydrochloride, neuroreceptor cells, nerve.

References

Vokhidov U. N. STATE OF COCHLEOVESTIBULAR DISORDERS IN PATIENTS WITH ARTERIAL HYPERTENSION //Oriental Journal of Medicine and Pharmacology. – 2022. – Т. 2. – №. 06. – С. 7-20.

Kari E. et al. A de novo SIX1 variant in a patient with a rare nonsyndromic cochleovestibular nerve abnormality, cochlear hypoplasia, and bilateral sensorineural hearing loss //Molecular genetics & genomic medicine. – 2019. – Т. 7. – №. 12. – С. e995.

Mei C. et al. Genetics and the individualized therapy of vestibular disorders //Frontiers in neurology. – 2021. – Т. 12. – С. 633207.

Vilchez‐Madrigal L. D. et al. Children with unilateral cochlear nerve canal stenosis have bilateral cochleovestibular anomalies //The Laryngoscope. – 2019. – Т. 129. – №. 10. – С. 2403-2408.

Ekobena P. et al. Four cases of audio-vestibular disorders related to immunisation with SARS-CoV-2 mRNA vaccines //International Journal of Audiology. – 2022. – С. 1-5.

Daneshi A. et al. Cochlear implantation in children with inner ear malformation: a multicenter study on auditory performance and speech production outcomes //International Journal of Pediatric Otorhinolaryngology. – 2020. – Т. 132. – С. 109901.

McNeill A. et al. SLC12A2 variants cause a neurodevelopmental disorder or cochleovestibular defect //Brain. – 2020. – Т. 143. – №. 8. – С. 2380-2387.

Lemasson J. et al. Cochleovestibular toxicity induced by immune checkpoint inhibition: a case series //European Journal of Cancer. – 2019. – Т. 117. – С. 116-118.

Sluydts M. et al. The relationship between cochleovestibular function tests and endolymphatic hydrops grading on MRI in patients with Menière’s disease //European Archives of Oto-Rhino-Laryngology. – 2021. – С. 1-11.

Khoza-Shangase K. Cochleovestibular findings linked to COVID-19: A scoping review for clinical care planning in South Africa //South African Journal of Communication Disorders. – 2022. – Т. 69. – №. 2. – С. 899.

Article Statistics

Copyright License

Download Citations

How to Cite

U.S. Khasanov, N.A. Akhunjhanov, G.S. Khaydarova, K.E. Shaykhova, & U.P. Abdullaev. (2023). USE OF BETASERCA IN PATIENTS WITH HD WITH COCHLEOVESTIBULAR DISORDERS. International Journal of Medical Sciences And Clinical Research, 3(04), 62–67. https://doi.org/10.37547/ijmscr/Volume03Issue04-09